Application

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97334141

Filing Date: 03/28/2022

To the Commissioner for Trademarks:

MARK: TORNADO THERAPEUTICS (Standard Characters, see mark)
The literal element of the mark consists of TORNADO THERAPEUTICS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Cambrian BioPharma, Inc., a corporation of Delaware, having an address of
      #66643
      228 Park Ave. South
      New York, New York 10003
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations and substances for the prevention of age-related physical decline, age-related diseases, infectious diseases, and Covid-19; pharmaceutical preparations and substances for the treatment of autoimmune diseases and inflammatory conditions, infectious diseases, fungal infections, mitochondrial myopathy and mitochondrial stress, oncology indications, metabolic indications, cardiovascular indications, neurodegenerative indications, and indications mediated by the mTOR pathway
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Scientific and technological services, namely pharmaceutical research and design relating thereto; pharmaceutical research and design services; scientific research in the fields of oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, the mTOR pathway, and mTOR inhibition; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials; medical research; provision of information and consultancy relating to medical and scientific research in the fields of oncology, aging, longevity, autoimmunity, dysregulated nutrient sensing, overactive cell signaling, and the mTOR pathway
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Carl Eppler. Other appointed attorneys are Edward R. Acheson, Samantha M. Berten, Taylor A. Bullard, Matthew J. Clark, Craig J. Cox, Matthew D. Delaney, Eric Lamb, Constance R. Lindman, Daniel A. Murray, Samantha M. Quimby, Matthew R. Schantz, Karlyn A. Schnapp, and Cynthia L. Stewart. Carl Eppler of Frost Brown Todd LLC, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      Suite 1900
      150 3rd Ave. South
      Nashville, Tennessee 37201
      United States
      615-251-5559(phone)
      615-251-5551(fax)
      ceppler@fbtlaw.com
The docket/reference number is 0735790.
Carl Eppler submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Carl Eppler

PRIMARY EMAIL FOR CORRESPONDENCE: ceppler@fbtlaw.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): ceppler@fbtlaw.com; rdarpel@fbtlaw.com; acunningham@fbtlaw.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Teri Champ/   Date: 03/28/2022
Signatory's Name: Teri Champ
Signatory's Position: General Counsel
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 97334141
Payment Accounting Date: 03/28/2022

Serial Number: 97334141
Internet Transmission Date: Mon Mar 28 15:59:20 ET 2022
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20220328155920360
152-97334141-820389d80a0a6d8481432514696
11201ced7a707988f0e1b61d91d377a7426e16e6
-CC-59193319-20220328153056665876